Hepatitis B At-Birth dose vaccine: An urgent call for implementation in Ghana

8Citations
Citations of this article
94Readers
Mendeley users who have this article in their library.

Abstract

Globally, approximately two billion people are infected with the Hepatitis B virus with attributable death estimated at about half a million people annually across the globe. Chronic hepatitis B infection is also an important public health problem in Ghana. The main mode of transmission in endemic regions is the perinatal route. Mother-to-child transmission can be reduced by antiviral therapy especially in the last trimester and adherence to the national immunization schedule. TheWorld Health Organization recommends to add the birth dose vaccine to the current expanded program on immunization (EPI) in all countries but especially for endemic regions. The evidence for the efficacy of the birth dose HBV vaccine is overwhelming and there is an urgent need for its introduction into the current EPI schedule in Ghana.

Cite

CITATION STYLE

APA

Awuku, Y. A., & Yeboah-Afihene, M. (2018, March 1). Hepatitis B At-Birth dose vaccine: An urgent call for implementation in Ghana. Vaccines. MDPI AG. https://doi.org/10.3390/vaccines6010015

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free